Skip to main content
Journal of Genetic Engineering & Biotechnology logoLink to Journal of Genetic Engineering & Biotechnology
. 2022 Aug 11;20:120. doi: 10.1186/s43141-022-00389-2

In silico mutational analysis to identify the role and pathogenicity of BCL-w missense variants

Poonam Kumari 1, Rashmi Rameshwari 1,
PMCID: PMC9372248  PMID: 35951173

Abstract

Background

Intrinsic pathway of apoptosis is generally mediated by BCL-2 (B cell lymphoma 2) family of proteins; they either induce or inhibit the apoptosis. Overexpression of BCL-2 in cancer cell may lead to delay in apoptosis. BCL-w is the pro-survival member of the BCL-2 family. BCL2L2 gene is present on chromosome number 14 in humans, and it encodes BCL-w protein; BCL-w protein is 193 amino acids residues in length. Interactions among the BCL-2 proteins are very specific. The fate of cell is determined by the ratio of pro-apoptotic proteins to pro-survival proteins. BCL-w promotes cell survival. Studies suggested that overexpression of BCL-w protein is associated with many cancers including DLBCL, BL, colorectal cancers, gastric cancers, and many more. The cause of overexpression is translocations or gene amplification which will subsequently result in cancerous activity.

Process

For in-silico analysis, BCL2L2 gene was retrieved from UniProt (UniProt ID: Q92843). 54 missense variants have been collected in BCL-w proteins from COSMIC database. Different tools were used to detect the deleteriousness of the variants.

Result

In silico mutational study reveals how the non-synonymous mutations directly affect the protein’s native structure and its function. Variant mutational analysis with PolyPhen-2 revealed that out of 55 variants, 28 of the missense mutations was probably damaging with a score ranging from 0.9 to 1, while 24 variants were benign with a score ranging from 0 to 0.4.

Conclusions

This in silico work aims to determine how missense mutations in BCL-w protein affect the activity of the protein, the stability of the protein, and to determine the pathogenicity of the variants. Prediction of pathogenicity of variants will reveal if the missense mutation has a damaging effect on the native structure of protein or not. Prediction of protein stability will reveal whether the mutation has a stabilizing or destabilizing effect on the protein.

Keywords: Pro-survival, Pathogenicity, Missense variants, Destabilizing, Deleterious, Stability

Background

BCL-2 family of proteins are associated with mitochondrial-mediated cell death. The proteins of BCL-2 family either inhibits or induces cell death. On the basis of BH domain, members are classified into three groups [1]. The pro-survival proteins possess BH1-4 domains e.g. BCL-2, BCL-XL, MCL1 [24], BCL-w, and A1/BFL-1. Multi-domain pro-apoptotic proteins contains BH1-3 domains, e.g., BAX and BAK [25], and lastly the BH3 only pro-apoptotic proteins which are further classified as activators or sensitizers. BAD, BIK, BMF are sensitizers and BIM, tBID, and PUMA are activators [2, 6]. Here, sensitizers do not bind to BAK and BAX [2, 7, 8] while the BH3 domain of the activators binds to BAK and BAX and induces conformational change that results in the oligomerization of these proteins in the outer membrane of the mitochondria, this oligomerization results in MOMP formation [2, 9]. In cytosol, cytochrome c (released from mitochondria intermembraned space) with Apaf-1, caspase 9, and ATP [1012] forms a complex also known as apoptosome. This complex cleaves off and activates the caspase 3 that results in apoptosis.

BCL-w is the pro-survival protein in the BCL-2 family. BCL2L2 gene present on chromosome number 14 in humans encodes the BCL-w protein and this protein is 193 amino acids residues in length [2, 13]. BCL-w protein is generally found on the outer membrane of the mitochondria [2, 14]. The BCL-w protein consists of nine α helices with flanking amphipathic helices α1 (10−24 residues), α2 (43−56), α3 (62−68), α4 (76−87), α6 (116−132), α7 (134−141), α8 (144−150), α9 (157−173), and central hydrophobic groove formed by helix, α5 (93−111).

BCL-w is found in the testes, colon, brains, and cells with lymphoid and myeloid origin [2, 13, 15]. Studies suggested that BCL-w is involved in spermatogenesis [2, 15] and is majorly expressed in spermatocytes, Leydig cells, Sertoli cells and spermatogonia, BCL-w also promotes their survival [2, 16, 17]. Experimental studies also suggest that overexpression of this protein might results in spermatocytes degeneracy, decline in the number of spermatogonia and vacuolization of sertoli cells [2, 18]. BCL-w also promotes the survival of gut epithelial cells [2, 15], prevents small intestine cells and mid-colon cells from death [2, 19], it also promotes enterocyte survival and B lymphocyte survival [2, 20]. High level of BCL-w also estimated in some areas of brain such as mature brain, sensory neurons, hippocampus and cerebellum [2, 21, 22]. BCL-w has also been involved in the development of dendrite and it controls the morphogenesis of mitochondria. BCL-w has also been involved in disorders of nervous system such as Alzheimer’s disease and Parkinson’s diseases, the cause of these diseases is the increased level of BCL-w. Overexpression of BCL-w is associated with ischemic brain [2, 23]. Overexpression of the BCL2L2 results in the survival of megakaryocytes and increased platelet formation [2, 24].

Genetic alterations in BCL2L2 contributes to many cancers such as copy number variations in small [2, 25] and non-small [2, 26] lung cancer, high level of BCL-w contributes to gastric carcinomas, and low BCL-w expression contributes to colorectal cancer [2, 27]. Patients with breast cancers significantly have high BCL-w mRNA level [2, 28, 29]. BCL-w has significantly involved with the cancer of urinary system [2, 30]. Overexpression of BCL-w is associated with cervical cancer, prostate cancer, hepatocellular carcinoma (HCC) and leiomyosarcomas. Expression of BCL-w is significantly higher in DLBCL, BL, CML [2, 31], and B-CLL [2, 32].

The interaction of pro-survival protein, i.e., BCL-w with pro-apoptotic proteins initiates the process of apoptosis but any dysregulation in these interactions will block the apoptotic pathway. Any chemical or amino acid alterations in the protein will interrupt the interactions between pro-survival proteins and pro-apoptotic proteins. Understanding of these mutations will help us to understand if the mutation is involved in any disease. This in silico study helps us to define the role of missense variants of BCL-w, which may alter proteins native structure and its function. By examining the role of mutation on biological function, we can determine the correlation between the mutation and the disease. The missense variants retrieved from this study were subjected to some in silico prediction tools such as Polyphen-2, SIFT, Provean, FATHMM, mutation assessor and stability prediction namely I-mutant 2.0, iStable, SAAFEC, SDM, DUET, and mCSM (Table 1).

Table 1.

Stability predictions of missense variants using various prediction tools by using fasta format as input

S.No Missense mutations I-Mutant2.0 MUpro SAAFEC IStable
1 A159V

0.78

Decrease

− 0.383

Decreasing

− 0.04

Destabilizing

Increase
2 G154W

– 1.56

Decrease

− 0.332

Decreasing

− 0.38

Destabilizing

Increase
3 R161H

− 0.73

Decrease

− 1.345

Decreasing

− 0.80

Destabilizing

Decrease
4 E146K

− 1.11

Decrease

− 1.300

Decreasing

− 0.57

Destabilizing

Decrease
5 L180Q

− 2.55

Decrease

− 1.839

Decreasing

− 1.68

Destabilizing

Decrease
6 V178M

− 3.82

Decrease

− 0.277

Decreasing

− 0.83

Destabilizing

Increase
7 A177P

0.87

Decrease

− 1.188

Decreasing

− 0.95

Destabilizing

Decrease
8 S169P

0.36

Increase

− 1.818

Decreasing

− 0.02

Destabilizing

Decrease
9 A159P

− 0.61

Decrease

− 1.71

Decreasing

− 0.41

Destabilizing

Decrease
10 A7T

− 0.97

Decrease

− 0.700

Decreasing

− 0.65

Destabilizing

Decrease
11 A7G

− 0.98

Decrease

− 1.108

Decreasing

− 0.70

Destabilizing

Decrease
12 A7V

0.89

Increase

− 0.458

Decreasing

− 0.64

Destabilizing

Increase
13 P8L

0.57

Increase

− 0.546

Decreasing

− 0.54

Destabilizing

Decrease
14 A15T

− 1.37

Decrease

− 1.302

Decreasing

− 0.85

Destabilizing

Decrease
15 D16H

− 1.53

Decrease

− 2.114

Decreasing

− 0.22

Destabilizing

Decrease
16 R23K

− 1.38

Decrease

− 0.717

Decreasing

− 0.74

Destabilizing

Decrease
17 G34W

− 1.01

Decrease

0.524

Increase

− 0.70

Destabilizing

Increase
18 M46T

− 0.80

Decrease

− 1.556

Decreasing

− 2.46

Destabilizing

Decrease
19 M46I

0.25

Increase

− 0.826

Decreasing

− 1.11

Destabilizing

Increase
20 R47Q

− 0.07

Decrease

− 0.786

Decreasing

− 1.06

Destabilizing

Increase
21 G50R

− 0.24

Decrease

− 1.055

Decreasing

− 0.76

Destabilizing

Increase
22 G50V

− 0.00

Increase

− 1.074

Decreasing

− 1.05

Destabilizing

Decrease
23 E54K

− 1.96

Decrease

− 1.066

Decreasing

− 0.59

Destabilizing

Decrease
24 F57S

− 1.69

Decrease

− 2.031

Decreasing

− 2.68

Destabilizing

Decrease
25 R58Q

− 0.45

Decrease

− 0.878

Decreasing

− 0.71

Destabilizing

Decrease
26 R59C

− 0.29

Decrease

− 1.086

Decreasing

− 0.49

Destabilizing

Decrease
27 R59H

− 0.90

Decrease

− 1.488

Decreasing

− 0.58

Destabilizing

Decrease
28 S62F

0.30

Increase

− 0.682

Decreasing

− 0.36

Destabilizing

Increase
29 A66D

− 0.23

Decrease

− 0.766

Decreasing

− 0.66

Destabilizing

Increase
30 P72T

− 0.88

Decrease

− 0.976

Decreasing

− 1.10

Destabilizing

Decrease
31 S74L

2.04

Increase

0.475

Increasing

− 0.48

Destabilizing

Increase
32 Q76K

− 0.13

Increase

− 0.978

Decreasing

− 0.60

Destabilizing

Decrease
33 R78H

− 1.33

Decrease

− 0.917

Decreasing

− 0.86

Destabilizing

Decrease
34 S83F

1.35

Increase

− 0.158

Decreasing

− 0.67

Destabilizing

Increase
35 D84N

0.36

Increase

− 0.895

Decreasing

0.18

Stabilizing

Increase
36 N92Y

− 0.64

Decrease

0.137

Increasing

− 0.58

Destabilizing

Increase
37 R95S

− 1.76

Decrease

− 1.048

Decreasing

− 1.36

Destabilizing

Decrease
38 R95H

− 0.69

Decrease

− 1.092

Decreasing

− 1.11

Destabilizing

Decrease
39 S110R

− 0.39

Increase

− 0.722

Decreasing

− 0.80

Destabilizing

Increase
40 V111I

− 0.58

Decrease

− 0.480

Decreasing

− 0.33

Destabilizing

Decrease
41 V127M

− 1.16

Decrease

− 0.536

Decreasing

− 0.46

Destabilizing

Decrease
42 A128V

− 0.55

Decrease

− 0.296

Decreasing

0.09

Stabilizing

Decrease
43 E131G

− 0.84

Decrease

− 1.672

Decreasing

− 0.81

Destabilizing

Decrease
44 Q133R

− 0.06

Decrease

− 1.196

Decreasing

− 0.08

Destabilizing

Increase
45 A135V

− 0.77

Decrease

− 0.525

Decreasing

− 0.17

Destabilizing

Increase
46 S140C

− 0.23

Increase

− 0.575

Decreasing

− 0.26

Destabilizing

Increase
47 S141I

0.91

Increase

− 0.269

Decreasing

− 0.06

Destabilizing

Increase
48 G142E

− 1.09

Decrease

− 1.223

Decreasing

− 1.27

Destabilizing

Decrease
49 G152R

− 1.38

Decrease

− 0.671

Decreasing

− 0.94

Destabilizing

Decrease
50 R160W

− 0.67

Decrease

− 0.744

Decreasing

− 0.88

Destabilizing

Decrease
51 R161L

− 0.12

Decrease

− 0.316

Decreasing

− 0.44

Destabilizing

Decrease
52 R163W

− 0.55

Decrease

− 0.852

Decreasing

− 0.06

Destabilizing

Decrease
53 R171M

− 0.88

Decrease

− 0.328

Decreasing

− 0.44

Destabilizing

Decrease
54 V186A

− 3.07

Decrease

− 1.789

Decreasing

− 1.41

Destabilizing

Decrease
55 A188P

− 1.42

Increase

− 1.343

Decreasing

− 0.76

Destabilizing

Increase

Bold represents a destabilizing or decreased mutational effect by all the prediction tools used

Method

Data collection—selection of the BCL-w variants

For in silico analysis, BCL2L2 gene was retrieved from UniProt (UniProt ID: Q92843). 54 missense variants have been collected in BCL-w proteins from COSMIC database. Among these, neither of the variants were listed in the ClinVar.

Variants pathogenicity prediction

For predicting the deleteriousness of the variants, the in silico pathogenicity prediction tools that were used were PolyPhen-2 [33], SIFT [34], Provean [3537], FATHMM [38], and Mutation Assessor [39].

Protein stability analysis

For predicting the of effect of amino acid change on the native BCL-w protein, I-mutant 2.0 [40], MUpro [41], and iStable [42], SAAFEC [43], SDM [44], DUET [45], and mCSM [46] web servers were used. I-mutant 2.0 is a web server that determines the change in stability due to point mutation or missense mutation. MUpro web server is a program that predicts the protein stability due to alteration in the sequence. Integrated predictor iStable was used for the predicting the stability of the protein, iStable may require both the sequence and the structure as an input. SAAFEC is a web server used to compute the energy changes due to single mutation. SDM (site-directed mutator) is an online server is that is also used for predicting the effect of point mutation on the protein stability. DUET is a web tool for the estimation of consequence of single mutation on proteins stability and its function. mCSM, a web tool used to estimate the impact of point mutation on protein stability, protein-protein-binding, and protein-DNA binding.

Result

Pathogenecity prediction of BCL-w missense variants

Variant mutational analysis with PolyPhen-2 revealed that out of 55 variants 28 of the missense mutations was probably damaging with score ranging from 0.9 to 1, while 24 variants were benign with score ranging from 0 to 0.4. PolyPhen-2 evaluates the damaging effect of point mutation by mapping SNPs to gene transcripts. From SIFT analysis, 28 out of 55 variants were deleterious, i.e., not tolerant with score ranging from 0 to 0.76, remaining 27 variants were tolerant (score range 0.76–1). Provean analysis revealed that 34 of the variants were neutral rest 20 were deleterious (one mutation, i.e., Q133R shows error) (Table 2). FATHMM analysis shows that 49 of the variants were deleterious, i.e., with score ≥ 0.67 rest 6 variants were neutral, i.e., no impact on the proteins native structure and function. Mutation assessor tool predicts the impact of point mutation on protein sequence and has revealed that 29 variants have low value while 15 variants have medium effect and 11 mutations have neutral effect.

Table 2.

Computational pathogenicity prediction scores of BCL-w variants

S.No Position PolyPhen-2 SIFT Provean Fathmm Mutation assessor
1 A159V

0.659

Probably damaging

1.00

Tolerant

− 1.031

Neutral

1.06

1.39

Low

2 G154W 0.938 Probably damaging

0.50

Not Tolerant

− 2.206

Neutral

0.90

1.39

Low

3 R161H 0.993 Probably damaging

1.00

Tolerant

− 1.065

Neutral

0.91

1.1

Low

4 E146K

0.365

Benign

0.94

Tolerant

− 0.118

Neutral

1.06

0.69

Neutral

5 L180Q

1.00

Probably damaging

0.94

Not tolerant

− 2.021

Neutral

0.70

1.67

Low

6 V178M

0.014

Benign

1.00

Not Tolerant

− 0.512

Neutral

0.78

1.5

Low

7 A177P 0.996 Probably damaging

1.00

Tolerant

− 1.640

Neutral

0.90

1.735

Low

8 S169P 0.998 Probably damaging

1.00

Tolerant

− 1.302

Neutral

0.97

1.735

Low

9 A159P 0.973 Probably damaging

1.00

Tolerant

− 1.477

Neutral

0.97

1.39

Low

10 A7T

0.001

Benign

0.38

Tolerant

0.093

Neutral

0.98

− 0.205

Neutral

11 A7G

0.003

Benign

0.38

Tolerant

− 0.272

Neutral

0.95

0.345

Neutral

12 A7V

0.018

Benign

0.38

Tolerant

− 1.56

Neutral

1.04

0

Neutral

13 P8L

0.028

Benign

0.38

Tolerant

− 0.548

Neutral

1.09

0.755

Neutral

14 A15T 0.519 Possibly damaging

0.94

Tolerant

− 0.676

Neutral

1.02

1.78

Low

15 D16H

0.965

Probably damaging

0.94

Not tolerant

− 2.623

Deleterious

0.64

1.905

Low

16 R23K

0.012

Benign

0.88

Tolerant

0.024

Neutral

0.91

0.205

Neutral

17 G34W

0.999

Probably damaging

1.00

Not tolerant

− 2.283

Neutral

0.78

0.825

Low

18 M46T

0.997

Probably damaging

1.00

Not tolerant

− 3.453

Deleterious

0.88

2.215

Medium

19 M46I

0.360

Benign

1.00

Not tolerant

− 0.984

Neutral

1.07

1.87

Low

20 R47Q

0.562

Possibly damaging

1.00

Tolerant

− 2.933

Deleterious

0.76

1.56

Low

21 G50R

1.000

Probably damaging

1.00

Not Tolerant

− 6.246

Deleterious

0.51

2.88

Medium

22 G50V

1.000

Probably damaging

1.00

Not tolerant

− 6.669

Deleterious

0.60

2.185

Medium

23 E54K

1.000

Probably damaging

1.00

Tolerant

− 2.725

Deleterious

0.99

2.855

Medium

24 F57S

0.964

Probably damaging

1.00

Not tolerant

− 5.229

Deleterious

0.97

2.215

Medium

25 R58Q

0.138

Benign

1.00

Tolerant

− 1.238

Neutral

0.93

2.215

Medium

26 R59C

0.001

Benign

1.00

Not tolerant

− 5.428

Deleterious

1.09

0.645

Neutral

27 R59H

0.099

Benign

1.00

Not tolerant

− 2.921

Deleterious

1.12

1.65

Low

28 S62F

0.993

Probably damaging

1.00

Not tolerant

− 4.105

Deleterious

0.86

2.25

Medium

29 A66D

0.001

Benign

1.00

Tolerant

− 1.132

Neutral

1.09

1.055

Low

30 P72T

0.986

Probably damaging

1.00

Not tolerant

− 6.239

Deleterious

0.87

2.805

Medium

31 S74L

0.557

Probably damaging

1.00

Tolerant

− 2.282

Neutral

0.81

1.795

Low

32 Q76K

0.142

Benign

1.00

Tolerant

− 1.504

Neutral

1.00

1.395

Low

33 R78H

0.280

Benign

1.00

Tolerant

− 2.066

Neutral

1.20

2.125

Medium

34 S83F

0.001

Benign

1.00

Not tolerant

− 0.852

Neutral

1.19

1.39

Low

35 D84N

0.073

Benign

1.00

Tolerant

− 1.032

Neutral

1.15

1.48

Low

36 N92Y

1.000

Probably damaging

1.00

Not tolerant

− 7.001

Deleterious

0.43

2.925

Medium

37 R95S

0.994

Probably damaging

1.00

Not tolerant

− 5.221

Deleterious

0.14

2.965

Medium

38 R95H

0.997

Probably damaging

1.00

Not tolerant

− 4.147

Deleterious

0.15

2.275

Medium

39 S110R

1.000

Probably damaging

1.00

Not tolerant

− 3.767

Deleterious

1.18

2.545

Medium

40 V111I

0.254

Benign

1.00

Tolerant

− 0.981

Neutral

0.84

1.795

Low

41 V127M

0.985

Probably damaging

1.00

Not tolerant

− 1.422

Neutral

0.84

1.745

Low

42 A128V

0.000

Benign

1.00

Tolerant

− 0.721

Neutral

0.96

0.435

Neutral

43 E131G

0.034

Benign

1.00

Tolerant

− 2.283

Neutral

1.08

1.645

Low

44 Q133R

0.000

Benign

1.00

Tolerant

Error 1.10

0.11

Neutral

45 A135V

0.067

Benign

1.00

Tolerant

− 1.765

Neutral

1.13

1.5

Low

46 S140C

0.987

Probably damaging

1.00

Not tolerant

− 3.590

Deleterious

0.87

2.16

Medium

47 S141I

0.000

Benign

1.00

Not tolerant

− 3.534

Deleterious

0.95

1.245

Low

48 G142E

0.996

Probably damaging

1.00

Not tolerant

− 6.273

Deleterious

− 1.69

2.875

Medium

49 G152R

0.999

Probably damaging

0.94

Not tolerant

− 3.741

Deleterious

0.85

1.445

Low

50 R160W

1.000

Probably damaging

1.00

Not tolerant

− 3.749

Deleterious

0.91

1.355

Low

51 R161L

0.945

Possibly damaging

1.00

Tolerant

− 2.168

Neutral

1.00

1.1

Low

52 R163W

1.000

Probably damaging

1.00

Not tolerant

− 1.314

Neutral

0.94

0.69

Neutral

53 R171M

0.406

Benign

0.75

Not tolerant

− 1.019

Neutral

0.97

0.69

Neutral

54 V186A

0.972

Probably damaging

0.62

Not tolerant

− 1.041

Neutral

0.03

1.39

Low

55 A188P

0.264

Benign

0.62

Tolerant

− 1.173

Neutral

0.01

1.795

Low

Note: PolyPhen-v2 score less than 0.5 is considered to be tolerated and more than 0.5 is considered to be deleterious. SIFT score ranges from 0.0 to 0.05 are considered to be deleterious while score near 1.0 are considered to be tolerated; Provean score equals to or below − 2.5 are considered to be deleterious while score above − 2.5 are considered to be neutral; FATHMM score equals to or above 0.67 are deleterious; mutation assessor score prediction: 0–1 is neutral, 1–2 low, and above 2 medium.

Protein stability analysis

Pathogenic missense mutations cause change in free energy which further leads to alteration in protein stability. Here, BCL-w variants were subjected to various protein stability tools for analyzing change in free energy due to point mutation. I-Mutant 2.0, MUpro, iStable, SAAFEC, SDM, DUET, and mCSM tools were used for determining the protein stability. The tools revealed that the variants decrease the protein stability by showing a destabilizing or decreasing energy as result. I-Mutant2.0, MUpro, mCSM, SDM, DUET, and SAAFEC tools shows the more negative ΔΔG value (ΔΔG > 0) shows the more destabilizing effect of the mutation, while the more positive ΔΔG value (ΔΔG <0) shows stability decrease in case of iStable tool.

Some of the servers require fasta format while some require PDB structure or PDB ID as an input. I-Mutant 2.0, MUpro, iStable, and SAAFEC use fasta format while SDM, DUET, and mCSM need PDB structure or PDB ID as an input. Some post-translational modifications that takes place during the conversion of peptide sequence to 3D structure may cause deletion of amino acids residue, i.e., some part of the protein may not be included in the crystallographic structure, as small peptide sequence yields a better crystal quality or structure of a protein is extracted from a crystal structure from proteins complex and isolating some proteins from complex of proteins may cause differences in the sequence in fasta format to sequence in PDB structure. Now, the fasta format of BCL-w starts from MATPA, while amino acid sequence in PDB structure starts from ATP, as shown in Fig. 1 for this reason, mutation given in DUET, SDM, and mCSM as A158V instead of A159V, besides this some of the amino acids are not included in the sequence of PDB structure due to these modifications are Q132R, V185A, and A187P as shown in Table 3.

Fig. 1.

Fig. 1

The amino acid sequence of BCL-w protein retrieved from RCSB PDB databank

Table 3.

DUET, mCSM, and SDM stability scores of BCL-w variants by using PDB format as input

S.No Variants SDM
(ΔΔG value in Kcal/mol)
DUET
(ΔΔG value in Kcal/mol)
mCSM
(ΔΔG value in Kcal/mol)
1 A158V

− 0.24

Destabilizing

0.108

Stabilizing

− 0.245

Destabilizing

2 G153W

− 0.28

Destabilizing

− 1.013

Destabilizing

− 1.167

Destabilizing

3 R160H

0.05

Stabilizing

− 1.148

Destabilizing

− 1.305

Destabilizing

4 E145K

− 0.46

Destabilizing

− 0.072

Destabilizing

− 0.372

Destabilizing

8 S168P

0.09

Stabilizing

− 0.073

Destabilizing

− 0.247

Destabilizing

9 A158P

− 3.0

Destabilizing

− 0.587

Destabilizing

− 0.245

Destabilizing

10 A6T

− 0.31

Destabilizing

− 0.333

Destabilizing

− 0.623

Destabilizing

11 A6G

− 0.24

Destabilizing

− 0.121

Destabilizing

− 0.385

Destabilizing

12 A6V

− 0.21

Destabilizing

− 0.255

Destabilizing

− 0.519

Destabilizing

13 P7L

− 0.32

Destabilizing

− 0.043

Destabilizing

− 0.308

Destabilizing

14 A14T

− 1.97

Destabilizing

− 0.734

Destabilizing

− 0.735

Destabilizing

15 D15H

0.35

Stabilizing

− 0.281

Destabilizing

− 0.546

Destabilizing

16 R22K

− 0.26

Destabilizing

− 0.78

Destabilizing

− 1.064

Destabilizing

17 G33W

0.04

Stabilizing

− 0.977

Destabilizing

− 1.242

Destabilizing

18 M45T

− 1.8

Destabilizing

− 1.22

Destabilizing

− 1.375

Destabilizing

19 M45I

− 0.03

Destabilizing

− 0.273

Destabilizing

− 0.784

Destabilizing

20 R46Q

− 0.17

Destabilizing

− 0.262

Destabilizing

− 0.522

Destabilizing

21 G49R

− 0.76

Destabilizing

− 0.694

Destabilizing

− 0.91

Destabilizing

22 G49V

0.47

Stabilizing

1.008

Stabilizing

0.49

Stabilizing

23 E53K

− 0.46

Destabilizing

− 0.166

Destabilizing

− 0.46

Destabilizing

24 F56S

− 3.23

Destabilizing

− 2.492

Destabilizing

− 2.231

Destabilizing

25 R57Q

− 0.44

Destabilizing

0.044

Stabilizing

− 0.059

Destabilizing

26 R58C

− 0.27

Destabilizing

− 0.319

Destabilizing

− 0.239

Destabilizing

27 R58H

0.29

Stabilizing

− 0.778

Destabilizing

− 0.833

Destabilizing

28 S61F

0.8

Stabilizing

− 0.651

Destabilizing

− 1.042

Destabilizing

29 A65D

− 0.94

Destabilizing

− 1.004

Destabilizing

− 1.205

Destabilizing

30 P71T

− 0.38

Destabilizing

− 0.346

Destabilizing

− 0.623

Destabilizing

31 S73L

1.24

Stabilizing

0.383

Stabilizing

− 0.146

Destabilizing

32 Q75K

0.17

Stabilizing

0.431

Stabilizing

− 0.054

Destabilizing

33 R77H

− 0.22

Destabilizing

− 1.464

Destabilizing

− 1.529

Destabilizing

34 S82F

0.64

Destabilizing

− 0.253

Destabilizing

− 0.543

Destabilizing

35 D83N

0.31

Stabilizing

− 0.637

Destabilizing

− 0.989

Destabilizing

36 N91Y

0.35

Stabilizing

− 0.403

Destabilizing

− 0.546

Destabilizing

37 R94S

− 3.2

Destabilizing

− 2.82

Destabilizing

− 2.249

Destabilizing

38 R94H

− 0.82

Destabilizing

− 2.229

Destabilizing

− 2.091

Destabilizing

39 S109R

0.1

Stabilizing

− 0.313

Destabilizing

− 0.78

Destabilizing

40 V110I

0.36

Stabilizing

− 0.313

Destabilizing

− 0.78

Destabilizing

41 V126M

− 0.11

Destabilizing

− 0.015

Destabilizing

− 0.239

Destabilizing

42 A127V

− 1.03

Destabilizing

− 0.25

Destabilizing

− 0.395

Destabilizing

43 E130G

− 1.53

Destabilizing

− 0.956

Destabilizing

− 0.802

Destabilizing

44 Q132R
45 A134V

− 0.97

Destabilizing

− 0.359

Destabilizing

− 0.51

Destabilizing

46 S139C

0.71

Stabilizing

0.227

Stabilizing

− 0.225

Destabilizing

47 S140I

2.13

Stabilizing

0.382

Stabilizing

− 0.467

Destabilizing

48 G141E

− 2.58

Destabilizing

− 0.705

Destabilizing

− 0.463

Destabilizing

49 G151R

0.14

Stabilizing

− 0.177

Destabilizing

− 0.607

Destabilizing

50 R159W

0.59

Stabilizing

− 0.531

Destabilizing

− 0.736

Destabilizing

51 R160L

− 0.08

Destabilizing

0.142

Stabilizing

− 0.022

Destabilizing

52 R162W

0.63

Stabilizing

− 0.757

Destabilizing

− 1.082

Destabilizing

53 R170M

0.14

Stabilizing

− 0.186

Destabilizing

− 0.073

Destabilizing

54 V185A
55 A187P

Bold represents destabilizing or decreased effect of the mutation

Discussion

Present in silico mutational study reveals how the non-synonymous mutations directly affect the proteins native structure and its function. The activity of the protein complex and its function depends on the complex formed between proteins; the interactions between proteins might be necessary for molecular features like cell signaling and cell regulation. The protein complex formed may be homodimer or heterodimer are formed due to interactions between proteins. The missense mutations at the interface of the protein-protein interaction (PPI) causes disruption in the shape, size, and secondary structure of the complex. For the specific function of the protein complex, there should be presence of stable interaction between proteins. Moreover, mutation of large amino acids into a smaller amino acid causes gaps while mutation of smaller one leads to bumps or inter-molecular clashes. BCL-w, has a pro-survival function, and is also involved in normal as well as diseased cells and disorders of nervous system and cancer. The protein–protein interactions gets disturbed due to non-synonymous mutation which may lead to diseased state. The structure of the protein is directly influenced by its function and its stability. The genetic variations, i.e., amino acid change that represses its property directly influences all other properties. The hydrogen bonds within amino acid residues maintains the protein stability, i.e., reduced H-bonds may cause loss of stability of the protein while higher H-bonds may increase the protein stability. The structural changes caused due to variants corresponds to physicochemical properties of the proteins like size, charge, hydrophobicity, molecular weight, and side chains. These changes further causes alteration in the chemical properties which may be necessary for maintaining secondary, tertiary, and quaternary structure of proteins.

Most pathogenic variants destabilizes the 3D structure, stability, and folding-free energy of the protein, which subsequently results in disruption in proteins function and regulation [47, 48].

Conclusion

Proteins are dynamic in nature as they are flexible in nature due to temperature, pH, and interaction with other molecule may be a ligand. Understanding of proteins native conformation may reveal the role of variants in diseased condition. The activity and function of the protein complex is determined by its interaction with other proteins. However, the stability of a protein complex can disrupt due to mutations in the protein. This in silico study has estimates the efficiency of various pathogenicity prediction tools and stability analysis tools for BCL-w variants and the study may help in characterization of mutations in the protein complex and molecular level. Furthermore, the result indicates that the missense mutation alters the stability of BCL-w.

Acknowledgements

I would like to express my sincere gratitude to Dr. Indrakant K Singh, assistant professor, Deshbandhu College, University of Delhi, for giving us the opportunity to work on this topic. It would never be possible for us to take this research work to this level without his innovative ideas and his relentless support and encouragement.

Abbreviations

MCL-1

Myeloid cell leukemia-1

BCL-w

B cell lymphoma-w

A1/BFL-1

BCL-2-related protein A1/BCL-2 related isolated from fetal liver-11

BAX

BCL-2-associated X protein

BAK

BCL-2 antagonist/killer

BAD

BCL-2-associated agonist of cell death

BIK

BCL-2 interacting killer

BMF

BCL-2-modifying factor

BIM

BCL-2-interacting mediator of cell death

tBID

Truncated form of BH3-interacting domain death agonist

PUMA

p53-upregulated modulator of apoptosis

MOMP

Mitochondrial outer membrane permeabilization

CML

Chronic myeloid lymphoma

Apaf-1

Apoptosis protease activating factor 1

B-CLL

B cell chronic lymphocytic leukemia

PolyPhen-2

Polymorphism phenotyping-2

SIFT

Sorting intolerant from tolerant

Provean

Protein variation effect analyzer

FATHMM

Functional analysis through hidden Markov models

Authors’ contributions

Both authors have contributed in research work and writing the manuscript. The author(s) read and approved the final manuscript.

Funding

No grant has been received.

Availability of data and materials

NA

Declarations

Ethics approval and consent to participate

No wet lab experiment is used so not required in the present work.

Consent for publication

Taken from co-author

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Poonam Kumari, Email: ppt7210@gmail.com.

Rashmi Rameshwari, Email: rashmi.fet@mriu.edu.in.

References

  • 1.Wong RSY. Apoptosis in cancer: From pathogenesis to treatment. J. Exp. Clin. Cancer Res. 2011;30(1):1–14. doi: 10.1186/1756-9966-30-87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hartman ML, Czyz M. BCL-w: apoptotic and non-apoptotic role in health and disease. Cell Death Dis. 2020;11:4. doi: 10.1038/s41419-020-2417-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat. Rev. Mol. Cell Biol. 2019;20(3):175–193. doi: 10.1038/s41580-018-0089-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hartman ML, Czyz M. Pro-apoptotic activity of BH3-only Proteins and BH3 Mimetics : from Theory to Potential Cancer Therapy. 2012. pp. 966–981. [DOI] [PubMed] [Google Scholar]
  • 5.Hartman ML, Czyz M. Anti-apoptotic proteins on guard of melanoma cell survival. Cancer Lett. 2013;331(1):24–34. doi: 10.1016/j.canlet.2013.01.010. [DOI] [PubMed] [Google Scholar]
  • 6.Dutta S, Gullá S, Chen TS, Fire E, Grant RA, Keating AE. Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL. J. Mol. Biol. 2010;398(5):747–762. doi: 10.1016/j.jmb.2010.03.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Knight T, Luedtke D, Edwards H, Taub JW, Ge Y. A delicate balance – The BCL-2 family and its role in apoptosis, oncogenesis, and cancer therapeutics. Biochem. Pharmacol. 2019;162:250–261. doi: 10.1016/j.bcp.2019.01.015. [DOI] [PubMed] [Google Scholar]
  • 8.Shamas-Din A, et al. Multiple partners can kiss-and-run: Bax transfers between multiple membranes and permeabilizes those primed by tBid. Cell Death Dis. 2014;5(6):e1277–e1277. doi: 10.1038/cddis.2014.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gama V, Deshmukh M. Life after MOMP. Mol. Cell. 2015;58(2):199–201. doi: 10.1016/j.molcel.2015.03.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell. 1998;1(7):949–957. doi: 10.1016/S1097-2765(00)80095-7. [DOI] [PubMed] [Google Scholar]
  • 11.Singh K, Briggs JM. Mutation research / reviews in mutation research functional implications of the spectrum of BCL2 mutations in lymphoma. Mutat. Res. Mutat. Res. 2016;769:1–18. doi: 10.1016/j.mrrev.2016.06.001. [DOI] [PubMed] [Google Scholar]
  • 12.Li P, et al. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91(4):479–489. doi: 10.1016/S0092-8674(00)80434-1. [DOI] [PubMed] [Google Scholar]
  • 13.Gibson L, et al. bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene. 1996;13(4):665–675. [PubMed] [Google Scholar]
  • 14.Lapham A, Adams JE, Paterson A, Lee M, Brimmell M, Packham G. The Bcl-w promoter is activated by β -catenin / TCF4 in human colorectal carcinoma cells. Gene. 2009;432(1–2):112–117. doi: 10.1016/j.gene.2008.12.002. [DOI] [PubMed] [Google Scholar]
  • 15.Reilly LAO, et al. Tissue expression and subcellular localization of the pro-survival molecule Bcl-w. 2001. pp. 486–494. [DOI] [PubMed] [Google Scholar]
  • 16.Yan W, Samson M, Je B, Toppari J. Bcl-w forms complexes with Bax and Bak, and elevated ratios of Bax / Bcl-w and Bak / Bcl-w correspond to spermatogonial and spermatocyte apoptosis in the testis. 2015. pp. 682–699. [DOI] [PubMed] [Google Scholar]
  • 17.Russell LD, et al. Spermatogenesis in Bclw-deficient mice1. Biol. Reprod. 2001;65(1):318–332. doi: 10.1095/biolreprod65.1.318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Yan WEI, et al. Overexpression of Bcl-w in the testis disrupts spermatogenesis : revelation of a role of BCL-W in. Mol Endocrinol. 2015;17:1868–1879. doi: 10.1210/me.2002-0389. [DOI] [PubMed] [Google Scholar]
  • 19.Pritchard DM, Print C, Reilly LO, Adams JM, Potten CS, Hickman JA. Bcl-w is an important determinant of damage-induced apoptosis in epithelia of small and large intestine. 2000. [DOI] [PubMed] [Google Scholar]
  • 20.Stern LE, et al. Epidermal growth factor alters the bax : bcl-w ratio following massive small bowel resection. J Surg Res. 2000;1(42):38–42. doi: 10.1006/jsre.2000.5897. [DOI] [PubMed] [Google Scholar]
  • 21.Skoglo Y. Differential expression of bcl-w and bcl-x messenger rna in the developing and adult rat nervous system. Neuroscience. 1999;91(2):673–684. doi: 10.1016/S0306-4522(98)00642-3. [DOI] [PubMed] [Google Scholar]
  • 22.Middleton G, Wyatt S, Ninkina N, Davies AM. Reciprocal developmental changes in the roles of Bcl-w and Bcl-x(L) in regulating sensory neuron survival. Development. 2001;128(3):447–57. doi: 10.1242/dev.128.3.447. [DOI] [PubMed] [Google Scholar]
  • 23.Zhu X, et al. Neuroprotective properties of Bcl-w in Alzheimer disease. 2004. pp. 1233–1240. [DOI] [PubMed] [Google Scholar]
  • 24.Pease-raissi SE, et al. Article paclitaxel reduces axonal Bclw to initiate IP 3 R1-dependent axon degeneration. Neuron. 2017;96(2):373–386.e6. doi: 10.1016/j.neuron.2017.09.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Kim YH, et al. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Oncogene. 2006;2005:130–138. doi: 10.1038/sj.onc.1208997. [DOI] [PubMed] [Google Scholar]
  • 26.Kawasaki T, et al. BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line. Cancer Sci. 2007;98(7):1070–1077. doi: 10.1111/j.1349-7006.2007.00491.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zhang B, et al. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway. Br. J. Cancer. 2014;110(4):946–957. doi: 10.1038/bjc.2013.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kim ES, Choi JY, Hwang SJ, Bae IH. Hypermethylation of miR-205-5p by IR governs aggressiveness and metastasis via regulating Bcl-w and Src. Mol. Ther. Nucleic Acid. 2019;14:450–464. doi: 10.1016/j.omtn.2018.12.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ding W, Ren J, Ren H, Wang D (2017) Long noncoding RNA HOTAIR modulates MiR-206-mediated Bcl-w signaling to facilitate cell proliferation in breast cancer. Sci. Rep.:1–9. 10.1038/s41598-017-17492-x [DOI] [PMC free article] [PubMed]
  • 30.Bo J, Yang G, Huo K, Jiang H, Zhang L, Liu D. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J. 2011;278:786–792. doi: 10.1111/j.1742-4658.2010.07997.x. [DOI] [PubMed] [Google Scholar]
  • 31.Raimondo S, et al. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism. 2015. pp. 1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sanz L, Garcia-marco A, Casanova B, Garc M, Garcia-pardo A, Silva A. Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells. Biochem Biophys Res Commun. 2004;315:562–567. doi: 10.1016/j.bbrc.2004.01.095. [DOI] [PubMed] [Google Scholar]
  • 33.Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. 2013;76:1. doi: 10.1002/0471142905.hg0720s76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Sim N-L, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40(W1):W452–W457. doi: 10.1093/nar/gks539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS One. 2012;7(10):e46688. doi: 10.1371/journal.pone.0046688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31(16):2745–2747. doi: 10.1093/bioinformatics/btv195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Choi Y (2012) A fast computation of pairwise sequence alignment scores between a protein and a set of single-locus variants of another protein, in Proceedings of the ACM Conference on Bioinformatics, Computational Biology and Biomedicine - BCB. 12:414–417. 10.1145/2382936.2382989
  • 38.Shihab HA, et al. Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum. Mutat. 2013;34(1):57–65. doi: 10.1002/humu.22225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 2011;39(17):e118–e118. doi: 10.1093/nar/gkr407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Capriotti E, Fariselli P, Casadio R. I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 2005;33:W306–W310. doi: 10.1093/nar/gki375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Cheng J, Randall A, Baldi P (2006) Prediction of protein stability changes for single-site mutations using support vector machines. 1132(2005):1125–1132. 10.1002/prot.20810 [DOI] [PubMed]
  • 42.Chen C-W, Lin J, Chu Y-W. iStable: off-the-shelf predictor integration for predicting protein stability changes. BMC Bioinformatics. 2013;14(S2):S5. doi: 10.1186/1471-2105-14-S2-S5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Li G, Panday SK, Alexov E. SAAFEC-SEQ: a sequence-based method for predicting the effect of single point mutations on protein thermodynamic stability. Int. J. Mol. Sci. 2021;22(2):606. doi: 10.3390/ijms22020606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Worth CL, Preissner R, Blundell TL. SDM--a server for predicting effects of mutations on protein stability and malfunction. Nucleic Acids Res. 2011;39(suppl):W215–W222. doi: 10.1093/nar/gkr363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Pires DEV, Ascher DB, Blundell TL (2014) DUET : a server for predicting effects of mutations on protein stability using an integrated computational approach. 42:314–319. 10.1093/nar/gku411 [DOI] [PMC free article] [PubMed]
  • 46.Pires DEV, Ascher DB, Blundell TL (2014) Structural bioinformatics mCSM : predicting the effects of mutations in proteins using graph-based signatures. 30(3):335–342. 10.1093/bioinformatics/btt691 [DOI] [PMC free article] [PubMed]
  • 47.Ajabnoor MA, Elango R, Banaganapalli B. Ac ce pt e cr t. J. Biomol. Struct. Dyn. 2019;0(0):000. doi: 10.1080/07391102.2019.1671899. [DOI] [Google Scholar]
  • 48.Hijikata A, Tsuji T, Shionyu M, Shirai T. Decoding disease-causing mechanisms of missense mutations from supramolecular structures. Sci. Rep. 2017;7(1):8541. doi: 10.1038/s41598-017-08902-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

NA


Articles from Journal of Genetic Engineering & Biotechnology are provided here courtesy of Academy of Scientific Research and Technology, Egypt

RESOURCES